Changes in Oral Corticosteroid Utilization in Patients with COPD Following Initiation of FF/UMEC/VI
International Journal of Chronic Obstructive Pulmonary Disease · 2023
DOI: 10.2147/copd.s419272 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Chronic Obstructive Pulmonary Disease, 2023. Verfasst von Michael Bogart und 5 weiteren Autor:innen. Beteiligte Einrichtung: US Value Evidence and Outcomes, GSK, Durham, NC, USA. Hauptthemen laut MEDLINE: Pulmonary Disease, Chronic Obstructive. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Themen: COPD
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- US Value Evidence and Outcomes, GSK, Durham, NC, USA.
- US Medical Affairs, GSK, Durham, NC, USA.
- US Medical Affairs, GSK, Collegeville, PA, USA.
- Merative, Ann Arbor, MI, USA.
ORCID-Profile: Michael Bogart, Carl B Abbott, Elizabeth R Packnett
Zitieren
APA
Bogart, M., Abbott, C. B., Bangalore, M., McMorrow, D., Packnett, E. R., & DiRocco, K. (2023). Changes in Oral Corticosteroid Utilization in Patients with COPD Following Initiation of FF/UMEC/VI. International Journal of Chronic Obstructive Pulmonary Disease. https://doi.org/10.2147/copd.s419272
Vancouver
Bogart M, Abbott CB, Bangalore M, McMorrow D, Packnett ER, DiRocco K. Changes in Oral Corticosteroid Utilization in Patients with COPD Following Initiation of FF/UMEC/VI. International Journal of Chronic Obstructive Pulmonary Disease. 2023. doi:10.2147/copd.s419272
BibTeX
@article{Bogart2023,
author = {Bogart, Michael and Abbott, Carl B and Bangalore, Mohan and McMorrow, Donna and Packnett, Elizabeth R and DiRocco, Kristi},
title = {Changes in Oral Corticosteroid Utilization in Patients with COPD Following Initiation of FF/UMEC/VI},
journal = {International Journal of Chronic Obstructive Pulmonary Disease},
year = {2023},
doi = {10.2147/copd.s419272}
}
EUVIMED